The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
Round Monodisperse Nanodiamonds: Towards Highly Bright, Biologically Inert Probes for Fluorescence Imaging
Schematic representation of FND (red) coated with thin (upper) or thick (bottom) silica layer and polymer (violet)
IOCB AS CR, CZ
NSTI Online Community